<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01475708</url>
  </required_header>
  <id_info>
    <org_study_id>EM-DOXY</org_study_id>
    <nct_id>NCT01475708</nct_id>
  </id_info>
  <brief_title>Doxycycline in Therapy of Erythema Migrans</brief_title>
  <official_title>Doxycycline in Therapy of Erythema Migrans - do the Accompanying Symptoms Influence the Outcome?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Medical Centre Ljubljana</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Medical Centre Ljubljana</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators will compare the outcome of three groups of erythema migrans patients
      treated with doxycycline: a group without any accompanying symptoms, with mild symptoms and
      with severe symptoms that require lumbar puncture.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with erythema migrans treated with doxycycline for two weeks will be followed-up for
      one year (at 2 weeks, 2, 6 and 12 months) clinically and also by filling in the questionnaire
      to assess the presence of certain symptoms. Also the control group of their friends or
      relatives without a history of Lyme borreliosis will be included. The presence of their
      (unspecific) symptoms will also be recorded by the questionnaire at the time of enrollment
      and at 6 and 12 months.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2011</start_date>
  <completion_date type="Actual">November 2014</completion_date>
  <primary_completion_date type="Actual">October 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Comparing of objective sequelae and post-treatment subjective symptoms in three groups of erythema migrans patients treated with doxycycline: with no accompanying symptoms, with mild and with severe symptoms at the beginning.</measure>
    <time_frame>1 year follow-up</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Comparison of subjective symptoms between erythema migrans patients treated with doxycycline and control subjects without a history of Lyme borreliosis.</measure>
    <time_frame>1 year follow-up</time_frame>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">400</enrollment>
  <condition>Lyme Borreliosis</condition>
  <arm_group>
    <arm_group_label>no symptoms</arm_group_label>
    <description>patients with erythema migrans and no additional newly onset symptoms treated with doxycycline</description>
  </arm_group>
  <arm_group>
    <arm_group_label>mild symptoms</arm_group_label>
    <description>patients with erythema migrans and mild unspecific newly onset symptoms treated with doxycycline</description>
  </arm_group>
  <arm_group>
    <arm_group_label>severe symptoms-lumbar puncture</arm_group_label>
    <description>patients with erythema migrans and newly onset intense &quot;neurologic&quot; symptoms with lumbar puncture performed, treated with doxycycline</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Doxycycline</intervention_name>
    <description>100 mg PO bid, 14 days</description>
    <arm_group_label>no symptoms</arm_group_label>
    <arm_group_label>mild symptoms</arm_group_label>
    <arm_group_label>severe symptoms-lumbar puncture</arm_group_label>
    <other_name>Doxy</other_name>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      whole blood, serum, cerebrospinal fluid, skin tissue
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with erythema migrans reffered to Lyme Borreliosis outpatient clinic of the
        University Medical Center Ljubljana, Slovenia, Department of Infectious Diseases.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  presence of erythema migrans

          -  &gt;15 years old

          -  informed consent

        Exclusion Criteria:

          -  pregnancy

          -  lactation

          -  multiple erythema migrans

          -  already treated with antibiotic for this episode of Lyme borreliosis

          -  allergy to doxycycline

          -  treatment with drugs with known interactions with doxycycline

          -  cerebrospinal fluid pleocytosis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Franc Strle, MD PhD</last_name>
    <role>Study Chair</role>
    <affiliation>UMC Ljubljana</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UMC Ljubljana, Department of Infectious Diseases</name>
      <address>
        <city>Ljubljana</city>
        <zip>1000</zip>
        <country>Slovenia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Slovenia</country>
  </location_countries>
  <verification_date>March 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 16, 2011</study_first_submitted>
  <study_first_submitted_qc>November 16, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 21, 2011</study_first_posted>
  <last_update_submitted>March 23, 2016</last_update_submitted>
  <last_update_submitted_qc>March 23, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 24, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Medical Centre Ljubljana</investigator_affiliation>
    <investigator_full_name>Franc Strle</investigator_full_name>
    <investigator_title>M.D., PhD</investigator_title>
  </responsible_party>
  <keyword>Lyme borreliosis</keyword>
  <keyword>Erythema migrans</keyword>
  <keyword>Doxycycline</keyword>
  <keyword>Subjective symptoms</keyword>
  <keyword>Outcome</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Erythema</mesh_term>
    <mesh_term>Erythema Chronicum Migrans</mesh_term>
    <mesh_term>Glossitis, Benign Migratory</mesh_term>
    <mesh_term>Borrelia Infections</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Doxycycline</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

